XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTANGIBLE ASSETS (Details ) (USD $)
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Finite-Lived Intangible Assets      
Accumulated Amortization $ (101,730)   $ (90,160)
Indefinite-Lived Intangible Assets      
Gross Carrying Amount     755,748
Net Amount     665,588
Gross Carrying Amount 968,837   755,748
Net Amount 867,107   665,588
Hormone therapy drug candidate patents (Member)
      
Finite-Lived Intangible Assets      
Gross Carrying Amount 387,806    
Accumulated Amortization (8,489)    
Net Amount 379,317    
Indefinite-Lived Intangible Assets      
Gross Carrying Amount 381,369   572,726
Net Amount 381,369   572,726
Multiple trademarks for vitamins/supplements (Member)
      
Indefinite-Lived Intangible Assets      
Gross Carrying Amount 75,968   59,328
Net Amount 75,968   59,328
OPERA software patent (Member)
      
Finite-Lived Intangible Assets      
Gross Carrying Amount 31,951   31,951
Accumulated Amortization (1,498)   (499)
Net Amount 30,453   31,452
Weighted Average Amortization Period 15 years 3 months 15 years 9 months 15 days  
Development costs for corporate website (Member)
      
Finite-Lived Intangible Assets      
Gross Carrying Amount 91,743   91,743
Accumulated Amortization (91,743)   (89,661)
Net Amount     $ 2,082
Weighted Average Amortization Period   4 months  
Hormone therapy drug candidate patents (Member)
      
Finite-Lived Intangible Assets      
Weighted Average Amortization Period 18 years 9 months